| Model Number |
FX385T |
| Medical Device Problem Code |
Mechanical Problem (1384)
|
| Health Effect - Clinical Code |
Hydrocephalus (3272)
|
| Date of Event |
05/22/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Manufacturing site evaluation: a recording of the manufacturing batch has been completed.No irregularities were found.As soon as the sample is available, the investigation will be completed and a supplementary medwatch report will be submitted.
|
| |
|
Event or Problem Description
|
|
It was reported that a progav 2.0 shuntsystem (#fx385t) was implanted.According to the complainant, the progav 2.0 valve had unintended shunt adjustment.4 years ago, the patient have a previously self- adjusted valve, too.The neurosurgeon suspected that the patient adjusted the shunt himself.The patient underwent a revision procedure and a new single pressure valve was implanted.The shunt is still in transit to manufacturer for examination.
|
| |
|
Event or Problem Description
|
|
The sample was recieved by the manufacturer and the investigation has been completed.
|
| |
|
Additional Manufacturer Narrative
|
|
Visual inspection
during the investigation, no significant deformations or damage of the valve were determined.Permeability test
a permeability test has shown that all components are permeable.Computer controlled test
to investigate, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the valves operate within the permissible tolerance in their respective relevant positions.Adjustment test
the progav 2.0 was tested and is adjustable to all specified pressures.Braking force and brake function test
the brake functionality test has shown that the brake function operates as expected and the braking force is within the given tolerances.Internal inspection
after dismantling of the valves, deposits were found in the progav 2.0.Results
based on our investigation results, we can determine visible deposits in the progav 2.0.The deposits had no effect upon the specifications at the time of the examination.Furthermore, we cannot determine functional deviations or other abnormalities in the shuntassistant 2.0.The shuntsystem operated within all specifications.Organic material in the csf can temporarily influence the function and are known side effects in hydrocephalus therapy.The examination of the return has been completed with the drafting of this report.A defect at the time of release can be excluded.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|
| |
|
Search Alerts/Recalls
|